DUBLIN–(BUSINESS WIRE)–The “Topical Drug Delivery Market Research Report by Product, Delivery Routing, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to from ResearchAndMarkets.com offer.
The global topical drug delivery market size was estimated to be USD 101.10 billion in 2021, USD 107.74 billion in 2022, and is projected to grow at a compound annual growth rate (CAGR) of 6.75% to reach USD 149.61 billion by 2027.
In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year and the years from 2023 to 2027 as the forecast period.
Cumulative impact of COVID-19:
The report provides insights into COVID-19 considering shifts in consumer behavior and demand, shopping patterns, supply chain rerouting, current market force dynamics, and significant interventions governments. The updated study provides insights, analysis, estimates, and forecasts considering the impact of COVID-19 on the market.
Cumulative impact of the 2022 Russian-Ukrainian conflict:
This controversy has severely affected lives and livelihoods and represents profound disruptions to business dynamics. The potential effects of the ongoing war and uncertainty in Eastern Europe are expected to negatively impact the global economy, with particularly harsh long-term effects on Russia.
This report reveals the impact of demand and supply, pricing variants, strategic vendor adoption, and recommendations for the Topical Drug Delivery market considering the current update on the conflict and its global response.
Competitive Strategy Window:
The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.
Market share analysis:
The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others.
Knowing the market share gives an idea of the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.
The report provides information about the following pointers:
Market Penetration: Provides comprehensive information on the market offered by major players
Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration in mature market segments
Market Diversification: Provides detailed information on new product launches, untapped geographies, recent developments, and investments
Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of key players
Product Development and Innovation: Provides intelligent insights into future technologies, R&D activities and breakthrough product developments
Enterprise Usability Profiles:
LLC absorption systems
Bausch Health Companies Inc.
Crescita Therapeutics Inc.
Glenmark Pharmaceuticals Limited
Hisamitsu Pharmaceutical Co., Inc.
Janssen Global Services, LLC
Merck & Co., Inc.
Novartis International SA
The company Lubrizol
Main topics covered:
2. Research methodology
3. Executive Summary
4. Market Overview
5. Market Overview
5.1. Market dynamics
22.214.171.124. High prevalence of skin diseases
126.96.36.199. Increase in the prevalence of eye diseases
188.8.131.52. High incidence of burns
184.108.40.206. Increase in the prevalence of diabetes
220.127.116.11. Preference for alternative modes of drug administration
18.104.22.168. Transdermal administration of biological products
22.214.171.124. Self-administration and home care
126.96.36.199. Technical barriers related to skin irritation and permeability
188.8.131.52. Drug failures and product recalls
5.2. Cumulative impact of COVID-19
5.3. Cumulative impact of the 2022 Russian-Ukrainian conflict
6. Topical Drug Delivery Market, By Product
6.2. Liquid formulations
6.2.2. pendant lights
6.3. Semi-solid formulations
6.4. Solid formulas
6.5. Transdermal products
6.5.1. Transdermal patches
6.5.2. Transdermal semi-solids
7. Topical Drug Administration Market, By Routing To Administration
7.2. Cutaneous administration of drugs
7.3. Nasal administration of drugs
7.4. Administration of ophthalmic drugs
7.5. Rectal administration of drugs
7.6. Vaginal administration of drugs
8. Topical Drug Delivery Market, By End User
8.2. Burning centers
8.3. Home care settings
8.4. Hospitals and Clinics
9. Americas Topical Drug Delivery Market
9.6. United States
10. Asia Pacific Topical Drug Delivery Market
11. Europe, Middle East & Africa Topical Drug Delivery Market
12. Competitive Landscape
12.1. FPNV positioning matrix
12.2. Market Ranking Analysis
12.3. Market share analysis, by key player
12.4. Competitive scenario
13. Enterprise Usability Profiles
For more information on this report, visit https://www.researchandmarkets.com/r/qweqvl